Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.380
-0.010 (-0.72%)
Feb 21, 2025, 4:00 PM EST - Market closed
Achilles Therapeutics Market Cap
Achilles Therapeutics has a market cap or net worth of $56.72 million as of February 21, 2025. Its market cap has increased by 51.55% in one year.
Market Cap
56.72M
Enterprise Value
-25.71M
1-Year Change
51.55%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since the IPO on March 31, 2021, Achilles Therapeutics's market cap has decreased from $731.19M to $56.72M, a decrease of -92.24%. That is a compound annual growth rate of -48.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 56.72M | 21.05% |
| Dec 31, 2024 | 46.85M | 29.23% |
| Dec 29, 2023 | 36.26M | -1.60% |
| Dec 30, 2022 | 36.84M | -81.89% |
| Dec 31, 2021 | 203.42M | -72.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |